Author
Texas Tech UniversityORCID 0000-0002-2163-7049Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Declan Bennett, Monika Wierdl, S Chakraborty…·Lillian M. Guenther
The paper develops ALTitude, a machine learning model to predict ALT status from whole genome sequencing data, identifies SMARCAL1 as a therapeutic target in ALT-driven cancers.
Md Hasnat Rashid, Moin Uddin Maruf, Troy Nations…·Indrajit Srivastava
This paper develops biomineralized SERS nanotags that encode biomolecular identity into machine learning-resolvable plasmonic fingerprints for diagnostic applications.
Katherine E. Baillie, Sijie Zhang, Veena Mathew…·Peter C. Stirling
The paper identifies DNA2 nuclease activity as a preferred therapeutic target in cancer by showing its essential role in DNA repair and fitness, with specific sensitivity in ALT+ tumors.